在阿尔茨海默病的小鼠模型中,大脑代谢网络的共变性和衰老
Evgeny J Chumin1,2,3, Charles P Burton1, Rebecca Silvola4,5
1Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|November 30, 2023
概括
这就是阿尔茨海默病的原因.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 医疗成像医学成像
背景情况:
- 阿尔茨海默氏症 (AD) 是导致痴呆的主要原因,对人类和经济产生重大影响.
- 阿尔茨海默病的有效治疗方法有限,需要新的诊断和治疗策略.
- 分子成像,特别是18F-FDG PET,可以评估大脑糖溶性代谢.
研究的目的:
- 在阿尔茨海默病的小鼠模型中研究与年龄和性别相关的脑代谢变化.
- 评估大脑代谢共变网络分析对跟踪AD进展的有用性.
- 评估代谢网络建模在阿尔茨海默病研究中的转化潜力.
主要方法:
- 18F-FDG正子发射断层扫描 (PET) 成像在5XFAD转基因小鼠和野生类型 (WT) 婴儿期对照中进行了4,6和12个月的成像.
- 用大脑代谢协变网络分析来分析区域葡萄糖摄取数据.
- 评估了跨年龄和性别的社区结构和协差网络中的代谢合.
主要成果:
- 与WT对照组相比,5XFAD小鼠表现出与年龄相关的葡萄糖吸收变化.
- 代谢协同变异网络分析揭示了跨年龄和性别的社区结构的显著差异.
- 在5XFAD模型中观察到代谢合的破坏,表明大脑网络功能发生了变化.
结论:
- 该研究使用小鼠模型成功复制了已知的阿尔茨海默病临床发现.
- 代谢网络共变性建模是评估AD进展的有价值的转化工具.
- 这种方法为评估治疗干预和了解疾病机制提供了潜力.
更多相关视频
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
19.2K
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
513
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
